January 15, 2026: FDA Posts Updates to Mounjaros Drug Warning Label, Strengthening Gastrointestinal Warnings On December 19, 2025, and January 7, 2026, the FDA published updates to Mounjaros drug warning label
Your body needs time to adjust to the drug, so nausea typically diminishes after the first few weeks
Limit high-fat and greasy foods (fried items, fatty meats, cream-based sauces), spicy foods, large portions, and carbonated beverages, especially during initial treatment and after dose increases, as these can worsen nausea, bloating, and gastrointestinal discomfort caused by delayed gastric emptying
Effects The effects of Retatrutide extend far beyond simple glucose regulation
No tirzepatide drops or oral semaglutide drops
Retatrutide activates three hormone receptors: GLP-1, GIP, and glucagon